Provided by Tiger Trade Technology Pte. Ltd.

AbCellera Biologics

11.32
-0.2500-2.16%
Post-market: 11.25-0.0700-0.62%19:59 EDT
Volume:4.55M
Turnover:51.80M
Market Cap:3.67B
PE:-20.75
High:11.80
Open:11.57
Low:11.14
Close:11.57
52wk High:12.15
52wk Low:2.75
Shares:324.00M
Float Shares:221.00M
Volume Ratio:0.50
T/O Rate:2.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5455
EPS(LYR):-0.4902
ROE:-17.30%
ROA:-10.39%
PB:4.09
PE(LYR):-23.09

Loading ...

Cantor Fitzgerald Initiates AbCellera Biologics at Overweight With $7 Price Target

MT Newswires Live
·
May 05

AbCellera initiated with an Overweight at Cantor Fitzgerald

TIPRANKS
·
May 05

Earning Preview: AbCellera Biologics this quarter’s revenue is expected to decrease by 24%, and institutional views are bullish

Earnings Agent
·
May 03

AbCellera Biologics announces annual shareholder meeting notice

Reuters
·
Apr 30

A Look At AbCellera Biologics (ABCL) Valuation After Its Planned ABCL635 Phase 1 Data Update

Simply Wall St.
·
Apr 24

Press Release: AbCellera to Highlight Phase 1 Clinical Data for ABCL635 During Upcoming First Quarter 2026 Earnings Call

Dow Jones
·
Apr 20

AbCellera updates financial calendar with upcoming quarterly earnings call

Reuters
·
Apr 20

Analysts Offer Insights on Healthcare Companies: AbCellera Biologics (ABCL), Telix Pharmaceuticals (OtherTLPPF) and Johnson & Johnson (JNJ)

TIPRANKS
·
Apr 15

How Investors Are Reacting To AbCellera Biologics (ABCL) After New Jones Trading Coverage Initiation

Simply Wall St.
·
Apr 13

AbCellera Biologics Initiated at Buy by Jones Trading

Dow Jones
·
Apr 10

AbCellera initiated with a Buy at JonesResearch

TIPRANKS
·
Apr 10

AbCellera Biologics (ABCL) Receives a Buy from Truist Financial

TIPRANKS
·
Apr 06

AbCellera schedules first-quarter earnings release, conference call

Reuters
·
Apr 02

3 Penny Stocks With Market Caps Under $19B To Watch

Simply Wall St.
·
Apr 01

A Look At AbCellera Biologics (ABCL) Valuation After Annual Earnings Reveal Higher Revenue And A Narrower Net Loss

Simply Wall St.
·
Mar 10

Major Investor Quietly Ramps Up Stake in AbCellera Biologics

TIPRANKS
·
Mar 03

Stock Track | AbCellera Biologics Soars 5.26% Intraday on Major Shareholder Acquisition

Stock Track
·
Mar 03

Insiders Quietly Double Down on AbCellera Biologics in Bold Buying Spree

TIPRANKS
·
Feb 28

Stock Track | AbCellera Biologics Soars 5.26% in After-Hours on Insider Buying by Major Shareholder and CFO

Stock Track
·
Feb 28

Thermopylae Holdings Ltd. Acquires AbCellera Biologics Common Shares

Reuters
·
Feb 28